| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/12/2011 | CA2396542C Composition promoting lacrimal secretion |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/12/2011 | CA2050318C Endothelial cell growth factor, methods of isolation and expression |
| 04/07/2011 | WO2011040651A1 Therapeutic agent for atopic dermatitis |
| 04/07/2011 | WO2011040600A1 NOVEL ANTIBACTERIAL AGENT TARGETING RESPONSE REGULATOR WaIR(YycF) |
| 04/07/2011 | WO2011040510A1 Indazole analogue |
| 04/07/2011 | WO2011040503A1 Method for recovery of sensitivity to anti-cancer agents in cancer cell that acquires resistance to anti-cancer agents |
| 04/07/2011 | WO2011040496A1 Heparanase activity inhibitor |
| 04/07/2011 | WO2011040495A1 Heparanase-activity inhibitor, wrinkle ameliorating agent containing same, and pharmaceutical composition |
| 04/07/2011 | WO2011040421A1 Screening method |
| 04/07/2011 | WO2011040220A1 Composition for treatment of pancreatic cancer |
| 04/07/2011 | WO2011040082A1 Laminin-332 production accelerating composition |
| 04/07/2011 | WO2011040004A1 Novel phenylpyridine derivative and medicinal agent comprising same |
| 04/07/2011 | WO2011038662A1 Compounds as trpv1 blockers, pharmaceutical compositions and medical uses thereof |
| 04/07/2011 | US20110082482 Materials and Methods for Nerve Repair |
| 04/07/2011 | US20110082281 Casein hydrolyzate, process for producing the same and use thereof |
| 04/07/2011 | US20110082277 Modified bio-related substance, process for producing the same, and intermediate |
| 04/07/2011 | US20110082203 Process to diagnose or treat brain injury |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082189 Use of compounds activating sirt-3 for mimicking exercise |
| 04/07/2011 | US20110082109 Novel acyl guanidine derivatives |
| 04/07/2011 | US20110082108 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 04/07/2011 | US20110082101 Combinations comprising epothilones and anti-metabolites |
| 04/07/2011 | US20110082100 Therapeutic substances that modulate genome methylation |
| 04/07/2011 | US20110082099 Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses |
| 04/07/2011 | US20110082094 Mammalian Cytokine-Like Polypeptide-10 |
| 04/07/2011 | US20110082093 Methods and compositions for treating trinucleotide repeat disorders |
| 04/07/2011 | US20110082081 Compositions and methods for repair of tissues |
| 04/07/2011 | US20110082072 Methods of Inhibiting Cell Death or Inflammation in a Mammal |
| 04/07/2011 | US20110081417 Surgical compositions |
| 04/07/2011 | US20110081400 Nutritional composition for bariatric surgery patients |
| 04/07/2011 | US20110081399 Surface modification of nitinol |
| 04/07/2011 | US20110081394 Methods of attaching a molecule-of-interest to a microtube |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081322 Elastin producing fibroblast formulations and methods of using the same |
| 04/07/2011 | US20110081318 Viral compositions and methods |
| 04/07/2011 | US20110081312 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 04/07/2011 | US20110081294 Contrast agent for photoacoustic imaging and photoacoustic imaging method |
| 04/07/2011 | DE102009042700A1 Medium (mineral wax, ozokerite or paraffin) and device, useful for heat treatment in chronic problems in locomotor apparatus e.g. in arthritis and muscle strain, comprise a carrier material, a base layer, a top layer and a plate |
| 04/07/2011 | CA2775464A1 Indazole analog |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305805A1 Double-stranded polynucleotide |
| 04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305794A1 Expansion of renewable stem cell populations |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305694A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305673A1 Crystal of thiazolidinedione compound, and process for production thereof |
| 04/06/2011 | EP2305672A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY |
| 04/06/2011 | EP2305663A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 04/06/2011 | EP2305648A1 Amide derivatives useful as glucokinase activators |
| 04/06/2011 | EP2305641A1 Sulfonamide compound or salt thereof |
| 04/06/2011 | EP2305629A1 Therapeutic agent for alzheimer's disease |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305306A1 Neuroinvasion inhibitor |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305304A1 Immunopotentiating agent comprising ep1 agonist |
| 04/06/2011 | EP2305301A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/06/2011 | EP2305291A1 Use of proteasome inhibitors for the treatment of HIV infections |
| 04/06/2011 | EP2305270A1 Anti-adhesive carbohydrates |
| 04/06/2011 | EP2305256A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/06/2011 | EP2305255A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/06/2011 | EP2305251A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of sexual disorder |
| 04/06/2011 | EP2305249A1 Membrane stabilising agent |
| 04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
| 04/06/2011 | EP2305241A1 Use of a 5'-nucleotide for preventing/improving functional digestive disorder |
| 04/06/2011 | EP2305233A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305232A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305231A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305223A1 Agent for activating stem cells |
| 04/06/2011 | EP2305217A1 Method for the preparation of pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors |
| 04/06/2011 | EP2303912A1 Cdca1 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303333A2 Conjugated vi saccharides |
| 04/06/2011 | EP2303278A1 Composition for modulating stem cell growth with prostaglandins |
| 04/06/2011 | EP2000473B1 Trehalose compound and pharmaceutical comprising the compound |
| 04/06/2011 | EP1878431B1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
| 04/06/2011 | EP1685832B1 Nerve regeneration promoters |
| 04/06/2011 | EP1602660B1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 04/06/2011 | EP1467749B1 Thrombin derived peptides for promoting cardiac tissue repair |
| 04/06/2011 | EP1404356B1 Method for designing cd10-activated prodrug compounds |
| 04/06/2011 | EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/06/2011 | EP1370277B1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 04/06/2011 | EP1303522B1 Biologically active macrolides, compositions, and uses thereof |
| 04/06/2011 | EP1255556B1 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN1977958B Chinese herbal medicine cold tea |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102002063A Dipeptide boric acid consisting of carboxylic acid and beta amino acid, and ester compound, preparation method and usage thereof |
| 04/06/2011 | CN102001959A Medicinal crystal as well as preparation method and application thereof |
| 04/06/2011 | CN102000274A Sugar-free fire clearing Chinese herbal granules and preparation method thereof |
| 04/06/2011 | CN102000233A Oral traditional Chinese medicine for knife wounds |
| 04/06/2011 | CN102000114A Injection egg white pig fattening agent and preparation method thereof |
| 04/06/2011 | CN101596260B Chinese patent medicine for treating epilepsy and postpartum epilepsy and preparation method thereof |